We are live on ! Find out more
NAGE

Niagen Bioscience
NAGE

65 hedge funds and large institutions have $54.7M invested in Niagen Bioscience in 2019 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 22 increasing their positions, 11 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

138% more call options, than puts

Call options by funds: $114K | Put options by funds: $48K

100% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 11

45% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 11

20% more capital invested

Capital invested by funds: $45.8M → $54.7M (+$8.97M)

8% more funds holding

Funds holding: 60 → 65 (+5)

1.76% more ownership

Funds ownership: 19.55% → 21.32% (+1.8%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
65
Holders Change
+5
Holders Change %
+8.33%
% of All Funds
1.28%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
16
Increased
22
Reduced
11
Closed
11
Calls
$114K
Puts
$48K
Net Calls
+$66K
Net Calls Change
+$77K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$714K
2
BlackRock
BlackRock
New York
+$541K
3
TCM
Tieton Capital Management
Washington
+$445K
4
State Street
State Street
Massachusetts
+$291K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$234K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$608K
2
GIP
Granite Investment Partners
California
-$276K
3
AWA
Arete Wealth Advisors
Illinois
-$177K
4
Renaissance Technologies
Renaissance Technologies
New York
-$157K
5
WG
Winton Group
United Kingdom
-$126K
Name Holding Trade Value Shares
Change 		Change in
Stake
BNP Paribas Financial Markets
51
BNP Paribas Financial Markets
France
$24.6K -$2.2K -618 -10%
Bank of Montreal
52
Bank of Montreal
Ontario, Canada
$22K +$6.02K +1,694 +49%
PCA
53
Peddock Capital Advisors
Massachusetts
$15K +$12K +3,380 New
AIP
54
Ameritas Investment Partners
Nebraska
$14K – – –
CPA
55
Cowen Prime Advisors
New York
$9K +$7.82K +2,200 New
TRCT
56
Tower Research Capital (TRC)
New York
$8K -$10.5K -2,952 -62%
TFA
57
Tobias Financial Advisors
Florida
$8K +$7.11K +2,000 New
Royal Bank of Canada
58
Royal Bank of Canada
Ontario, Canada
$6K +$3.56K +1,003 +207%
AA
59
AlphaMark Advisors
Kentucky
$3K – – –
WWM
60
Willingdon Wealth Management
North Carolina
$3K – – –
Fidelity Investments
61
Fidelity Investments
Massachusetts
$3K +$2.67K +750 New
AG
62
Advisor Group
Arizona
$1K +$960 +270 New
RE
63
RBC Europe
United Kingdom
$715 – – –
Millennium Management
64
Millennium Management
New York
– -$608K -154,733 Closed
AWA
65
Arete Wealth Advisors
Illinois
– -$177K -44,924 Closed
Renaissance Technologies
66
Renaissance Technologies
New York
– -$157K -39,900 Closed
WG
67
Winton Group
United Kingdom
– -$126K -32,037 Closed
Susquehanna International Group
68
Susquehanna International Group
Pennsylvania
– -$101K -28,470 Closed
EGM
69
Engineers Gate Manager
New York
– -$108K -27,443 Closed
AQR Capital Management
70
AQR Capital Management
Connecticut
– -$91K -23,024 Closed
Commonwealth Equity Services
71
Commonwealth Equity Services
Massachusetts
– -$74K -19,022 Closed
VF
72
Virtu Financial
New York
– -$71K -18,155 Closed
LPL Financial
73
LPL Financial
California
– -$45K -11,330 Closed
HS
74
Horan Securities
United States
– -$9K -2,210 Closed
Simplex Trading
75
Simplex Trading
Illinois
– +$252 +71 New
1 2
3
4

NAGE Hedge Fund Activity: Q4 2019 in Review

65 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Niagen Bioscience (NAGE) for Q4 2019, worth a combined $54.7M — up 20% from $45.8M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new NAGE positions and 11 closed out — a net gain of 5 holders — while 22 added to existing stakes and 11 trimmed.

The largest buyer was Vanguard Group, adding an estimated $714K. The largest seller was Millennium Management, exiting entirely with an estimated $608K sold.

  • 65 institutional investors held Niagen Bioscience (NAGE) as of Q4 2019, up from 60 in Q3 2019.
  • Funds reported $54.7M of Niagen Bioscience stock for Q4 2019, up 20% quarter-over-quarter.
  • 16 funds opened new Niagen Bioscience positions in Q4 2019 and 11 closed out, a net change of +5 holders.
  • The largest Niagen Bioscience buyer in Q4 2019 was Vanguard Group, an estimated $714K added.
  • The largest Niagen Bioscience seller in Q4 2019 was Millennium Management, an estimated $608K sold.

Based on aggregated 13F filings for Q4 2019.